By Suzanne McGee (Reuters) - Exchange operator CBOE Global Markets filed a request with the U.S. Securities and Exchange Commission on Monday seeking to list exchange-traded funds (ETFs) tied to cryptocurrency Solana, requiring the agency to make a decision by March. Under SEC rules, the agency has 240 calendar days to decide whether to approve or deny CBOE's "19b-4" application to list the products from VanEck and digital asset manager 21Shares. They are the first proposed ETF products tied to the price of Solana, the fifth largest cryptocurrency, according to CoinGecko. VanEck and 21Shares in June applied with the SEC to launch the new products. The SEC must also approve those "S-1" filings before the products can begin trading, but the agency's rules do set a deadline for those investor disclosure filings. If approved, the products would mark a third wave of spot cryptocurrency ETFs, after the SEC in January approved ETFs tied to the price of bitcoin, in a watershed for the industry. Such products require a two-stage approval process. "We are now addressing the increasing investor interest in Solana – the third most actively traded cryptocurrency after Bitcoin and Ether," said Rob Marrocco, global head of ETP Listings at Cboe. VanEck, 21Shares and other issuers are also waiting on the final green light from the SEC to launch ETFs tied to the spot price of the second-largest cryptocurrency, ethereum. That go-ahead is likely to come within the next week, said two people familiar with the process. Regulators have already approved the exchanges' application to list and trade those new products. The price of Solana is hovering around $137.83, down from last month's peak of nearly $150 when the two ETF filings were first submitted, CoinGecko data showed. (Reporting by Suzanne McGee, Editing by Michelle Price and Richard Chang)
Cboe files for SEC approval to list Solana ETFs, starts clock for required decision
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...